HAVN Life Sciences & Optimi Health Corp Announce Supply Agreements, Here Are The Details

Benzinga Real-time News · 06/29/2022 03:30

Two publicly traded psychedelics companies announced supply agreements. HAVN Life Sciences (OTC:HAVLF) will provide mental health clinic MPB Group Inc. with psilocybin-containing mushrooms for its therapeutic retreats in Jamaica and Optimi Health Corp. (OTCQX:OPTHF) will supply psychedelics-assisted therapy center SABI Mind with psilocybin and MDMA. HAVN Life is a biotech psychedelics company developing standardized extraction of psychoactive compounds, natural health products and innovative therapies to support brain health. MPB Group Inc., partnered with NGO Healing Escapes Foundation, will utilize the allocated psychoactive mushrooms on their holistic mental health retreats for couples and adults in Jamaica,

View Full Text on the app

Risk disclosure: The above content only represents the opinion of the authors or guests, and does not represent any positions of Futu or constitute any investment advice on the part of Futu. Before making any investment decision, investors should consider the risk factors related to investment products based on their own circumstances and consult professional investment advisers where necessary. Futu makes every effort to verify the authenticity, accuracy, and originality of the above content, but does not make any guarantees or promises.